As seen on:
As seen on:
Latest Articles
How reinvesting dividends creates compounding growth, turns steady payouts into accelerating wealth, and why patient investors benefit most over time.
Unlock Asia’s next growth wave with these 3 healthcare stocks.
The government’s equity stimulus could reshape market sentiment, but its impact on dividends for retail investors deserves closer scrutiny.
Buried under all that market noise, this high-yield stock may offer steady income and upside.
The Smart Reads of the Year brings together the stories that defined 2025. From blue-chip compounding and CPF-beating dividends to REITs built for income and overlooked small caps with tailwinds, these were the ideas that mattered beyond market noise.
A quiet SGX holiday week saw a surprise REIT takeover bid, debt relief for Manulife US REIT, and NVIDIA’s largest-ever US$20 billion AI acquisition.
Popular
Three unlikely blue-chip winners emerged in August, highlighting the market’s diversity.
These REITs have done well this year, but can they continue to surge higher?
We track the good performance of these five blue-chip stocks to assess if they qualify as good investment candidates.
The telco has trained its sights on growing its revenue and profits under its ST28 long-term plan.
Stocks
Selling a winning stock is often harder than buying one — but the right decision depends on fundamentals, valuation, and portfolio balance, not emotions.
AI demand and rental hikes are boosting DPUs for these 3 S-REITs. Here is what investors should know.
These five types of Singapore stocks offer pricing power, steady cash flows, and income growth that can help protect wealth in 2026.
We look at Lendlease REIT’s expansion, Centurion and Wilmar’s earnings, the S$1.2B UI Boustead REIT IPO, and Netflix’s strategic pivot in this week’s market highlights.